Effects of consumption of the test food on muscle stiffness in healthy Japanese women

Effects of consumption of the test food on muscle stiffness in healthy Japanese women: an open-label trial - Effects of consumption of the test food on muscle stiffness in healthy Japanese women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048279

Enrollment

Registered

2022-07-05

Start date

2022-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 12 weeks Test food: BRE3 extract tablet Administration: Take one tablet with licking and dissolving before activity (such as morning and pre-exercise) once a day. At the same time, do diap

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Women 3. Subjects aged 35 or more and less than 59 4. Healthy subjects 5. Subjects who feel body stiffness

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who suffer from COVID-19 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who have a regular exercise habit (such as "subjects who take a walk everyday" and "subjects who go to a yoga class once a week") 11. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

Measure	Time frame
1. Muscle stiffness at 12 weeks after consumption (12w)	—

Secondary

Measure	Time frame
1. Muscle stiffness at four weeks after consumption (4w) 2. Subjective symptom measured by visual analogue scale (VAS) at 4w and 12w 3. Body weight, body mass index, body fat percentage, and basal metabolism at 4w and 12w	—

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026